Skip to main content
SpringerLink
Log in

Identification of novel inhibitors of mitogen-activated protein kinase phosphatase-1 with structure-based virtual screening

  • Published:
Journal of Computer-Aided Molecular Design Aims and scope Submit manuscript

Abstract

Mitogen-activated protein kinase phosphatase-1 (MKP-1) has proved to be an attractive target for the development of therapeutics for the treatment of cancer. We report the first example for a successful application of the structure-based virtual screening to identify the novel inhibitors of MKP-1. It is shown that the efficiency of virtual screening can be enhanced significantly by the incorporation of a new solvation energy term in the scoring function. The newly found inhibitors have desirable physicochemical properties as a drug candidate and reveal a moderate potency with IC50 values ranging from 20 to 50 μM. Therefore, they deserve a consideration for further development by structure–activity relationship studies to optimize the inhibitory activities. Structural features relevant to the stabilization of the inhibitors in the active site of MKP-1 are discussed in detail.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jeffery KL, Camps M, Rommel C, Mackay CR (2007) Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 6:391–403

    Article  Google Scholar 

  2. Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M (1997) Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab Invest 76:37–51

    CAS  Google Scholar 

  3. Liao Q, Guo J, Kleeff J, Zimmermann A, Büchler MW, Korc M, Friess H (2003) Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells. Gastroenterology 124:1830–1845

    Article  CAS  Google Scholar 

  4. Denkert C, Schmitt WD, Berger S, Reles A, Pest S, Siegert A, Lichtenegger W, Dietel M, Hauptmann S (2002) Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma. Int J Cancer 102:507–513

    Article  CAS  Google Scholar 

  5. Kikuchi K, Nakamura K, Shima H (1999) Protein phosphatases and cancer. Curr Top Biochem Res 1:75–87

    CAS  Google Scholar 

  6. Vogt A, Tamewitz A, Skoko J, Sikorski RP, Giuliano KA, Lazo JS (2005) The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J Biol Chem 280:19078–19086

    Article  CAS  Google Scholar 

  7. Lazo JS, Nunes R, Skoko JJ, de Oliveira PEQ, Vogt A, Wipf P (2006) Novel benzofuran inhibitors of human mitogen-activated protein kinase phosphatase-1. Bioorg Med Chem 14:5643–5650

    Article  CAS  Google Scholar 

  8. Cao S, Murphy BT, Foster C, Lazo JS, Kingston DGI (2009) Bioactivities of simplified adociquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases. Bioorg Med Chem 14:2276–2281

    Article  Google Scholar 

  9. Shoichet BK, Leach AR, Kuntz ID (1999) Ligand solvation in molecular docking. Proteins 34:4–16

    Article  CAS  Google Scholar 

  10. Jeong DG, Jung SK, Yoon TS, Woo EJ, Kim JH, Park BC, Ryu SE, Kim SJ (2009) Crystal structure of the catalytic domain of human MKP-2 reveals a 24-mer assembly. Proteins 76:763–767

    Article  CAS  Google Scholar 

  11. Baker D, Sali A (2001) Protein structure prediction and structural genomics. Science 294:93–96

    Article  CAS  Google Scholar 

  12. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779–815

    Article  CAS  Google Scholar 

  13. Jeffrey GA (1997) An introduction to hydrogen bonding. Oxford University Press, Oxford

    Google Scholar 

  14. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliver Rev 23:3–25

    Article  CAS  Google Scholar 

  15. Gasteiger J, Rudolph C, Sadowski J (1990) Automatic generation of 3D atomic coordinates for organic molecules. Tetrahedron Comput Method 3:537–547

    Article  CAS  Google Scholar 

  16. Gasteiger J, Marsili M (1980) Iterative partial equalization of orbital electronegativity-a rapid access to atomic charges. Tetrahedron 36:3219–3228

    Article  CAS  Google Scholar 

  17. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639–1662

    Article  CAS  Google Scholar 

  18. Park H, Lee J, Lee S (2006) Critical assessment of the automated AutoDock as a new docking tool for virtual screening. Proteins 65:549–554

    Article  CAS  Google Scholar 

  19. Cornell WD, Cieplak P, Bayley CI, Gould R, Merz KM Jr, Ferguson DM, Spellmeyer DC, Fox T, Caldwell J, Kollman PA (1995) A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc 117:5179–5197

    Article  CAS  Google Scholar 

  20. Park H, Jeon YH (2007) Cubic equation governing the outer-region dielectric constant of globular proteins. Phys Rev E 75:021916

    Article  Google Scholar 

  21. Stouten PFW, Frömmel C, Nakamura H, Sander C (1993) An effective solvation term based on atomic occupancies for use in protein simulations. Mol Simul 10:97–120

    Article  CAS  Google Scholar 

  22. Kang H, Choi H, Park H (2007) Prediction of molecular solvation free energy based on the optimization of atomic solvation parameters with genetic algorithm. J Chem Inf Model 47:509–514

    Article  CAS  Google Scholar 

  23. Sippl MJ (1993) Recognition of errors in three-dimensional structures of proteins. Proteins 17:355–362

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Grant No. K11061 from the Korea Institute of Oriental Medicine (KIOM). A Hanyang University Internal Grant also supported this study.

Author information

Authors and Affiliations

  1. Department of Bioscience and Biotechnology, Sejong University, 98 Kunja-Dong, Kwangjin-Ku, Seoul, 143-747, Korea

    Hwangseo Park

  2. Department of Bioengineering, Hanyang University, 17 Haengdang-dong, Seongdong-gu, Seoul, 133-791, Korea

    Jeong-Yi Jeon, Song Yi Kim & Seong Eon Ryu

  3. Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology, 52 Eoeun-Dong, Yuseong-Gu, Daejeon, 305-333, Korea

    Dae Gwin Jeong

Authors
  1. Hwangseo Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeong-Yi Jeon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Song Yi Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dae Gwin Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seong Eon Ryu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hwangseo Park.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, H., Jeon, JY., Kim, S.Y. et al. Identification of novel inhibitors of mitogen-activated protein kinase phosphatase-1 with structure-based virtual screening. J Comput Aided Mol Des 25, 469–475 (2011). https://doi.org/10.1007/s10822-011-9432-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10822-011-9432-2

Keywords

Search

Navigation